95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
20.55%
Revenue growth above 1.5x OR's 9.92%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
20.55%
Gross profit growth above 1.5x OR's 10.18%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-8.75%
Negative EBIT growth while OR is at 15.15%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-8.75%
Negative operating income growth while OR is at 7.56%. Joel Greenblatt would press for urgent turnaround measures.
-56.84%
Negative net income growth while OR stands at 26.20%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-83.65%
Negative EPS growth while OR is at 21.43%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-83.65%
Negative diluted EPS growth while OR is at 21.43%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-92.10%
Negative OCF growth while OR is at 11.49%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-92.10%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
26.10%
10Y revenue/share CAGR under 50% of OR's 191.83%. Michael Burry would suspect a lasting competitive disadvantage.
26.10%
5Y revenue/share CAGR at 75-90% of OR's 29.95%. Bill Ackman would encourage strategies to match competitor’s pace.
21.17%
Positive 3Y CAGR while OR is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.50%
Firm’s AR is declining while OR shows 8.62%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
2.99%
Inventory growth of 2.99% while OR is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
1.10%
Asset growth well under 50% of OR's 3.85%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
1.57%
Under 50% of OR's 5.86%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
300.27%
SG&A growth well above OR's 19.74%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.